Reply on “Vitamin D and coronary atherosclerosis”.
Osteoporosis and Sarcopenia.2017;3(4):202-202. doi:10.1016/j.afos.2017.11.004
No abstract available.
Osteoporosis and Sarcopenia
2002 (v1, n1) to Present ISSN: 1671-8925
Year of publication
Sort by
DISPLAY OPTIONS
Format:
Per page:
Vitamin D and coronary atherosclerosis.
Osteoporosis and Sarcopenia.2017;3(4):201-201. doi:10.1016/j.afos.2017.11.003
Sarcopenia in elderly patients with chronic low back pain.
Osteoporosis and Sarcopenia.2017;3(4):195-200. doi:10.1016/j.afos.2017.09.001
OBJECTIVES: The prevalence of chronic low back pain (CLBP) increases with age and several mechanisms are involved in the development of CLBP, including osteoporosis; however, no associations with sarcopenia have yet been identified. METHODS: In total, 100 patients with CLBP and 560 patients without CLBP (nCLBP) aged over 65 years were studied. Skeletal muscle mass index (SMI) and percentage of body fat were evaluated using wholebody dual-energy X-ray absorptiometry. Sarcopenia was diagnosed when the relative SMI was more than 2 standard deviations below the mean in young adults. Thus, the cutoff value for sarcopenia was defined according to Sanada's Japanese population data. Paraspinal muscle cross-sectional areas of the lumbar multifidus and the erector spinae muscles were calculated using magnetic resonance imaging. RESULTS: Forty patients (40.0%) from the CLBP group and 149 (26.6%) from the nCLBP group met the criteria of sarcopenia. SMI was significantly lower and the body fat ratio was significantly higher in the CLBP group compared with the nCLBP group. Sarcopenic obesity was significantly observed in the CLBP group. Lumbar multifidus and the erector spinae muscle cross sectional area were significantly lower in the CLBP group. CONCLUSIONS: Elderly patients with CLBP have significantly lower skeletal muscle mass, and age-related mechanisms in sarcopenia are considered to be associated with chronic pain. Therapeutic procedures that are used to treat elderly aging muscle, including muscle strengthening and performance training, can possibly be a treatment for or used to prevent elderly CLBP.
Absorptiometry, Photon ; Adipose Tissue ; Aged* ; Aging ; Asian Continental Ancestry Group ; Chronic Pain ; Humans ; Low Back Pain* ; Magnetic Resonance Imaging ; Muscle, Skeletal ; Muscles ; Obesity ; Osteoporosis ; Paraspinal Muscles ; Prevalence ; Sarcopenia* ; Young Adult
Absorptiometry, Photon ; Adipose Tissue ; Aged* ; Aging ; Asian Continental Ancestry Group ; Chronic Pain ; Humans ; Low Back Pain* ; Magnetic Resonance Imaging ; Muscle, Skeletal ; Muscles ; Obesity ; Osteoporosis ; Paraspinal Muscles ; Prevalence ; Sarcopenia* ; Young Adult
Osteoporosis and Sarcopenia.2017;3(4):192-194. doi:10.1016/j.afos.2017.11.005
OBJECTIVES: There remains controversy over osteoporotic feature of the ankle. Therefore, we investigated the possibility of the existence of a relationship between axial bone mineral density (BMD) in patients with ankle fracture group with that of the normal population in Korea under control of other confounding factors such as body mass index (BMI). METHODS: This study retrospectively reviewed medical records of patients who were treated in our institution from 2005 to 2015. A comparative analysis was carried out between 116 patients with ankle fracture (ankle fracture group) and 113 patients admitted with other orthopedic reasons (control group). Sex, age, energy level of trauma, and BMI were analyzed as variables affecting axial BMD. RESULTS: Age and sex of ankle fracture group were not different from them of control group (P = 0.968 and P = 0.870, respectively). BMI of ankle fracture group was higher than that of control (P = 0.029). The other variables showed no differences between the 2 groups. The energy level of trauma in ankle fracture group was related to only BMI (P = 0.013). CONCLUSIONS: Axial BMD of ankle fracture patients showed no difference from that of a control group in Korean population. The occurrence of ankle fracture is affected by only BMI rather than axial BMD. Evaluation of osteoporosis for patients with ankle fracture should be considered separately.
Ankle Fractures* ; Ankle* ; Body Mass Index ; Bone Density* ; Humans ; Korea ; Medical Records ; Orthopedics ; Osteoporosis* ; Retrospective Studies ; Risk Factors*
Ankle Fractures* ; Ankle* ; Body Mass Index ; Bone Density* ; Humans ; Korea ; Medical Records ; Orthopedics ; Osteoporosis* ; Retrospective Studies ; Risk Factors*
Osteoporosis and Sarcopenia.2017;3(4):185-191. doi:10.1016/j.afos.2017.11.001
OBJECTIVES: Glucocorticoid (GC) treatment inhibits activation of runt-related transcription factor 2 (Runx2), which is essential for osteoblast differentiation from stem cells. As a result, GC treatment results in bone loss, GC-induced osteoporosis (GIO), elevated fracture risk, and delayed bone healing. Bisphosphonates such as alendronate (ALN) are recommended for treating or preventing GIO, and lowintensity pulsed ultrasound (LIPUS) facilitates fracture healing and maturation of regenerated bone. Combined therapy with ALN and LIPUS may stimulate cancellous bone healing in GIO rats. Here, we examined the effect of ALN and LIPUS on cancellous bone osteotomy repair in the proximal tibia of GIO rats. METHODS: Prednisolone (10 mg/kg body weight/day) was administered for 4 weeks to induce GIO in 6-month-old female Sprague-Dawley rats. Tibial osteotomy was then performed and daily subcutaneous injection of ALN (1-µg/kg body weight) was subsequently administered alone or in combination with LIPUS (20 min/day) for 2 or 4 weeks. RESULTS: ALN significantly increased bone mineral density (BMD) at 2 and 4 weeks, and ALN + LIPUS significantly increased BMD at 4 weeks. Bone union rates were significantly increased after 2 and 4 weeks ALN and ALN + LIPUS treatment. Lastly, ALN and ALN + LIPUS significantly increased the proportion of Runx2 positive cells at 4 weeks. CONCLUSIONS: ALN monotherapy and combined ALN and LUPUS treatment augmented BMD and stimulated cancellous bone repair with increased Runx2 expression at the osteotomy site in GIO rats. However, the combined treatment had no additional effect on cancellous bone healing compared to ALN monotherapy.
Alendronate* ; Animals ; Bone Density ; Bone Diseases, Metabolic* ; Diphosphonates ; Female ; Fracture Healing ; Humans ; Infant ; Injections, Subcutaneous ; Osteoblasts ; Osteoporosis ; Osteotomy* ; Prednisolone ; Rats* ; Rats, Sprague-Dawley ; Stem Cells ; Tibia* ; Transcription Factors ; Ultrasonic Waves*
Alendronate* ; Animals ; Bone Density ; Bone Diseases, Metabolic* ; Diphosphonates ; Female ; Fracture Healing ; Humans ; Infant ; Injections, Subcutaneous ; Osteoblasts ; Osteoporosis ; Osteotomy* ; Prednisolone ; Rats* ; Rats, Sprague-Dawley ; Stem Cells ; Tibia* ; Transcription Factors ; Ultrasonic Waves*
Osteoporosis and Sarcopenia.2017;3(4):174-184. doi:10.1016/j.afos.2017.10.002
OBJECTIVES: This study aimed to identify factors associated with initiation and adherence of osteoporosis medication from a patient perspective. METHODS: A web-based survey was developed based on health behavior theories. Descriptive analyses were conducted for all survey items. Analyses in a structural equation modeling framework were conducted to identify factors associated with treatment initiation and adherence. RESULTS: Five hundred forty-five women completed the questionnaire. A majority were currently receiving medications for osteoporosis (n = 376, 69.0%) and 25.0% of these patients (n = 94) were considered adherent to their treatment. Knowledge was strongly associated with osteoporosis treatment initiation (standard error [SE], 0.58). Greater knowledge of disease was associated with increased likelihood of initiating medication. Medication complexity (SE, 0.49) and perceived susceptibility to fracture and loss of independence (SE, −0.37) were also associated with initiation. Perceived barriers (SE, −0.85) such as inconvenience, lack of efficacy and financial burden were observed to be the greatest obstacle to adherence. The greater the perceived barriers, the less likely patients were to adhere to medication. Patients' perception of self-efficacy (SE, 0.37) also affected adherence. The greater the patient perception of ability to independently manage their medication, the more likely they were to adhere to the medication. CONCLUSIONS: Different factors were found to be associated with initiation and adherence of osteoporosis medication. Patient knowledge of their disease and the perception of barriers were found to be the most influential. Empowering patients with the knowledge to better understand their disease and decreasing the perception of barriers through education initiatives may be effective in improving patient outcomes.
Education ; Female ; Health Behavior ; Humans ; Japan* ; Osteoporosis* ; Patient-Centered Care
Education ; Female ; Health Behavior ; Humans ; Japan* ; Osteoporosis* ; Patient-Centered Care
Calcemic response to burns differs between adults and children: A review of the literature.
Osteoporosis and Sarcopenia.2017;3(4):170-173. doi:10.1016/j.afos.2017.10.001
OBJECTIVES: The calcemic and parathyroid hormone (PTH) responses to severe burn injury appear to differ between children and adults. In our limited studies children exhibited hypocalcemic hypoparathyroidism consistent with up-regulation of the parathyroid calcium-sensing receptor (CaSR) while adults did not, suggesting a developmental cutoff in cytokine-mediated up-regulation of the CaSR. This difference may be clinically important as published studies indicate that extracellular calcium (Ca) may stimulate the inflammatory response. The aim of this study was to examine the existing literature on burns to see if the differences between pediatric and adult calcemic and PTH responses to burn supported our findings providing stronger evidence to support this developmental difference. METHODS: We reviewed the National Library of Medicine database using the terms burns, PTH and ionized calcium and found 9 articles from 8 different medical centers; one was eliminated due to mixing of adults and children. RESULTS: There were 245 burn patients reported from the literature, 178 pediatric and 67 adults. The data are mostly consistent with our reported findings. Of the 10 pediatric patients with severe burns that we studied, mean ionized Ca concentration was below the lower limit of normal of 1.10 mM. The 67 adult burn patients reported in the literature had a mean blood ionized Ca concentration that was within the adult normal range or was lower than normal but with secondary hyperparathyroidism. Moreover, serum PTH concentrations were uniformly low in the 178 children in the burn literature but normal or mildly elevated in the 67 adults. CONCLUSIONS: These results support the hypothesis that the difference between pediatric and adult victims is consistent with an age-related CaSR response to cytokine stimulation and may be consistent with a lower level of inflammation in children. Ionized Ca and PTH might serve as possible therapeutic targets to lower the inflammatory response in burn victims.
Adult* ; Burns* ; Calcium ; Child* ; Humans ; Hyperparathyroidism, Secondary ; Hypoparathyroidism ; Inflammation ; National Library of Medicine (U.S.) ; Parathyroid Hormone ; Receptors, Calcium-Sensing ; Reference Values ; Up-Regulation
Adult* ; Burns* ; Calcium ; Child* ; Humans ; Hyperparathyroidism, Secondary ; Hypoparathyroidism ; Inflammation ; National Library of Medicine (U.S.) ; Parathyroid Hormone ; Receptors, Calcium-Sensing ; Reference Values ; Up-Regulation
Surgical treatment of severe osteoporosis including new concept of advanced severe osteoporosis.
Osteoporosis and Sarcopenia.2017;3(4):164-169. doi:10.1016/j.afos.2017.11.006
Severe osteoporosis is classified as those with a bone mineral density (BMD) T-score of −2.5 or lower, and demonstrate one or more of osteoporotic, low-trauma, fragility fractures. According to the general principle of surgical approach, patients with severe osteoporosis require not only more thorough pre- and postoperative treatment plans, but improvements in surgical fixtures and techniques such as the concept of a locking plate to prevent bone deformity and maximizing the blood flow to the fracture site by using a minimally invasive plate osteosynthesis. Arthroplasty is often performed in cases of displaced femoral neck fracture. Otherwise internal fixation for the goal of bone union is the generally accepted option for intertrochanteric, subtrochanteric, and femoral shaft fractures. Most of osteoporotic spine fracture is stable compression fracture, but vertebroplasty or kyphoplasty may be performed some selective patients. If neurological paralysis, severe spinal instability, or kyphotic deformity occurs, open decompression or fusion surgery may be considered. In order to overcome shortcomings of the World Health Organization definition of osteoporosis, we proposed a concept of ‘advanced severe osteoporosis,’ which is defined by the presence of proximal femur fragility fracture or two or more fragility fractures in addition to BMD T-score of −2.5 or less. In conclusion, we need more meticulous approach for surgical treatment of severe osteoporosis who had fragility fracture. In cases of advanced severe osteoporosis, we recommend more aggressive managements using parathyroid hormone and receptor activator of nuclear factor kappa-B ligand monoclonal antibody.
Arthroplasty ; Bone Density ; Congenital Abnormalities ; Decompression ; Femoral Neck Fractures ; Femur ; Fractures, Compression ; Humans ; Kyphoplasty ; Osteoporosis* ; Paralysis ; Parathyroid Hormone ; Spine ; Vertebroplasty ; World Health Organization
Arthroplasty ; Bone Density ; Congenital Abnormalities ; Decompression ; Femoral Neck Fractures ; Femur ; Fractures, Compression ; Humans ; Kyphoplasty ; Osteoporosis* ; Paralysis ; Parathyroid Hormone ; Spine ; Vertebroplasty ; World Health Organization
Osteoporosis and Sarcopenia.2017;3(4):161-163. doi:10.1016/j.afos.2017.11.002
Osteoporosis and Sarcopenia.2016;2(4):257-258. doi:10.1016/j.afos.2016.10.003
No abstract available.
Country
Republic of Korea
Publisher
ElectronicLinks
Editor-in-chief
Abbreviation
Osteoporosis and Sarcopenia
Vernacular Journal Title
ISSN
2405-5255
EISSN
Year Approved
2016
Current Indexing Status
Currently Indexed
Start Year
Description
Powered by IMICAMS(
备案号: 11010502037788, 京ICP备10218182号-8)